CTOs on the Move

INmuneBIO

www.inmunebio.com

 
INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient`s immune system to treat cancer. INKmune, the company`s lead product, primes patient`s NK cells (natural killer cells) to kill cancer.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.inmunebio.com
  • 1200 Prospect Street Suite 525
    La Jolla, CA USA 92037
  • Phone: 858.964.3720

Executives

Name Title Contact Details

Funding

INmuneBIO raised $25M on 07/20/2020
INmuneBIO raised $15M on 06/14/2021

Similar Companies

Ginkgo Bioworks

At Ginkgo Bioworks we are expanding the role of biology in our world.Nature`s biodiversity holds answers to challenges in health, energy, food, materials, and more. Organism Engineers at Ginkgo learn from Nature to develop new organisms that replace technology with biology.

Biolex Therapeutics

Biolex Therapeutics is a Pittsboro, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Two Pore

Two Pore Guys has created a digital, hand-held, single molecule biosensor that rivals the sensitivity of expensive medical lab equipment, yet is as inexpensive and easy to use as a blood glucose monitor.

In Vivo Scientific

In Vivo Scientific is a Valley Park, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HilleVax

HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.